Aranesp (darbepoetin alfa) / Kyowa Kirin, Amgen  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

2 Trials

   Remove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Aranesp (darbepoetin alfa) / Amgen, Kyowa Kirin
SMART, NCT05936021: Clinical Validation Study for Optimization of Anemia MAnagement in Hemodialysis Patients With End Stage Kidney Disease Using the Dialysis Anemia TReatmenT Model

Active, not recruiting
N/A
80
US
Algorithm model-based Aranesp doses, Standard of care
Intermountain Health Care, Inc.
Dialysis
11/24
01/25
EPOASA, NCT04330729: The Effect of Salicylate on Platelet Function in CKD (Chronic Kidney Disease) Patients Treated With Aranesp

Recruiting
N/A
60
Europe
Acetylsalicylic acid
Zealand University Hospital
Erythropoietin Adverse Reaction
12/26
12/26

Download Options